Kiniksa Pharmaceuticals Class A financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

키닉사 파머슈티컬스 인터내셔널NASDAQ:KNSA · Nasdaq · Healthcare · sector #17

$77.96+1.13%

2026-10-07 close

Kiniksa Pharmaceuticals Class A's published financial data is dated 2026-10-04. 2024 revenue was $423M. 2024 operating profit was −$46M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy